Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513208 · ClinicalTrials.gov registry record · Phase 4
Ketorolac Effects on Post-operative Pain and Lumbar Fusion
A Phase 4 study of Lumbar Spinal Fusion, sponsored by University of Maryland St. Joseph Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT06513208: Recruiting Phase 4 study of Lumbar Spinal Fusion, sponsored by University of Maryland St. Joseph Medical Center.
NCT06513208 is a Phase 4 study of Lumbar Spinal Fusion that is actively recruiting participants, run by University of Maryland St. Joseph Medical Center. The registered enrollment target is 140 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06513208, a Phase 4 study of Lumbar Spinal Fusion, is actively recruiting participants, sponsored by University of Maryland St. Joseph Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ketorolac Tromethamine
Study Locations (1)
Maryland
- University of Maryland St. Joseph Medical Center - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2026-01 |
| Est. Completion | 2027-06 |
| Phase | Phase 4 |
What NCT06513208 shows while recruiting
NCT06513208 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Lumbar Spinal Fusion appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06513208 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06513208 about?
NCT06513208 is a clinical study titled "Ketorolac Effects on Post-operative Pain and Lumbar Fusion". A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
What is the current status of trial NCT06513208?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2026-01. Estimated completion is 2027-06.
What conditions does trial NCT06513208 study?
This clinical trial studies the following conditions: Lumbar Spinal Fusion.
What interventions are being tested in trial NCT06513208?
The interventions under investigation include: Placebo (DRUG), Ketorolac Tromethamine (DRUG).
Who is sponsoring clinical trial NCT06513208?
This trial is sponsored by University of Maryland St. Joseph Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513208 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06513208's enrollment target sits among peer trials
140 581st of 2000 higher than 1,409 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia